Organon (OGN) Other Non-Current Liabilities (2020 - 2026)

Organon (OGN) recorded quarterly Other Non-Current Liabilities of $984.0 million in Q1 2026, down 2.38% quarter-over-quarter from $1.0 billion in Q4 2025, and down 1.01% on a YoY basis from $994.0 million in Q1 2025.

Organon (OGN) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Organon's Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $984.0 million for Q1 2026.

  • In Q1 2026, Other Non-Current Liabilities fell 1.01% year-over-year to $984.0 million; the TTM figure through Mar 2026 stood at $984.0 million (down 1.01% YoY), while the FY2025 annual figure was $1.0 billion, up 3.17% from the prior year.
  • Other Non-Current Liabilities was $984.0 million for Q1 2026 at Organon, down from $1.0 billion in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $1.1 billion in Q3 2025 to a low of $393.0 million in Q2 2023.
  • Historically, Other Non-Current Liabilities has averaged $669.3 million across 5 years, with a median of $548.0 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities slumped 75.42% in 2022, then soared 137.14% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $411.0 million in 2022, then rose by 0.24% to $412.0 million in 2023, then jumped by 137.14% to $977.0 million in 2024, then climbed by 3.17% to $1.0 billion in 2025, then fell by 2.38% to $984.0 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $984.0 million (Q1 2026), $1.0 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn
10 Organon 3.49 Bn 2.37 Bn 783.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 984.00 Mn
Dec 31, 2025 1.01 Bn
Sep 30, 2025 1.12 Bn
Jun 30, 2025 1.12 Bn
Mar 31, 2025 994.00 Mn
Dec 31, 2024 977.00 Mn
Sep 30, 2024 674.00 Mn
Jun 30, 2024 548.00 Mn
Mar 31, 2024 549.00 Mn
Dec 31, 2023 412.00 Mn
Sep 30, 2023 421.00 Mn
Jun 30, 2023 393.00 Mn
Mar 31, 2023 421.00 Mn
Dec 31, 2022 411.00 Mn
Sep 30, 2022 441.00 Mn
Jun 30, 2022 448.00 Mn
Mar 31, 2022 454.00 Mn
Dec 31, 2021 463.00 Mn
Sep 30, 2021 506.00 Mn
Jun 30, 2021 487.00 Mn